BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4123820)

  • 1. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate.
    Thomson DS; Evans DP
    Clin Exp Immunol; 1973 Apr; 13(4):537-44. PubMed ID: 4123820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disodium cromoglycate and human reagin (IgE) mediated reactions. Effect on wheal and flare skin reactions and histamine release from rat mast cells in vitro.
    Haddad ZH; Gillman SA
    Int Arch Allergy Appl Immunol; 1973; 45(3):439-46. PubMed ID: 4133791
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
    Evans DP; Marshall PW; Thomson DS
    Int Arch Allergy Appl Immunol; 1975; 49(4):417-27. PubMed ID: 51008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of allergic reactions by cromoglycate and by a new series of compounds (AH 6556, AH 7079 and AH 7725).
    Assem ES
    Int Arch Allergy Appl Immunol; 1973; 45(5):708-18. PubMed ID: 4127175
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells.
    Kusner EJ; Dubnick B; Herzig DJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):41-6. PubMed ID: 4119619
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis.
    Chiang G; Patra P; Letourneau R; Jeudy S; Boucher W; Green M; Sant GR; Theoharides TC
    J Urol; 2000 Dec; 164(6):2119-25. PubMed ID: 11061939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig.
    Taylor WA; Roitt IM
    Int Arch Allergy Appl Immunol; 1973; 45(6):795-807. PubMed ID: 4128404
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.
    Sheard P; Blair AM
    Int Arch Allergy Appl Immunol; 1970; 38(2):217-24. PubMed ID: 4189435
    [No Abstract]   [Full Text] [Related]  

  • 10. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechansim of tachyphylaxis to ICI 74,917 and disodium cromoglycate.
    Marshall PW; Thomson DS; Evans DP
    Int Arch Allergy Appl Immunol; 1976; 51(3):274-83. PubMed ID: 58840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro.
    Free CA; Hall LE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):437-40. PubMed ID: 6162946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gastrointestinal mast cell in food allergy.
    Saavedra-Delgado AM; Metcalf DD
    Ann Allergy; 1983 Aug; 51(2 Pt 1):185-9. PubMed ID: 6410939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats.
    Johnson HG; van Hout CA
    Int Arch Allergy Appl Immunol; 1976; 50(4):446-53. PubMed ID: 55394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new antiallergic drugs (cromolyn sodium, lodoxamide tromethamine). What is the role of cholinergic stimulation in the biphasic dose response?
    Johnson HG; White GJ
    Monogr Allergy; 1979; 14():299-306. PubMed ID: 91955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in guinea pigs.
    Nabe T; Yamamoto M; Suga M; Kohno S
    Eur J Pharmacol; 2004 Aug; 497(1):97-104. PubMed ID: 15321740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-allergic compounds on anaphylactic histamine secretion from rat peritoneal mast cells in the presence and absence of exogenous calcium.
    White JR; Pearce FL
    Immunology; 1982 Jun; 46(2):361-7. PubMed ID: 6177625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.